PMR Predicts a Stable Overlook for the Equine Veterinary Therapeutics Market Size Growth, which is Driven by Rising Need for Specialized Care and Treatment for Horses
Industry: Healthcare
Published Date: June-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 142
Report ID: PMRREP33965
1. Executive Summary
1.1. Global Equine Veterinary Therapeutics Market Snapshot, 2024 and 2033
1.2. Market Opportunity Assessment, 2024-2033, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Drugs Lifecycle Analysis
2.4. Equine Veterinary Therapeutics Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Equine Veterinary Therapeutics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Equine Veterinary Therapeutics Market Outlook: Drugs
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Drugs, 2019-2023
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2024-2033
3.3.3.1. Anti- Inflammatory
3.3.3.2. Anti - Infective
3.3.3.3. Parasiticides
3.3.3.4. Others
3.4. Market Attractiveness Analysis: Drugs
3.5. Global Equine Veterinary Therapeutics Market Outlook: Route of Administration
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Route of Administration, 2019-2023
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2024-2033
3.5.3.1. Oral
3.5.3.2. Parental
3.5.3.3. Topical
3.6. Market Attractiveness Analysis: Route of Administration
3.7. Global Equine Veterinary Therapeutics Market Outlook: Service
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Service, 2019-2023
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2024-2033
3.7.3.1. Diagnostic Tests and Imaging
3.7.3.2. Physical Health Monitoring
3.7.3.3. Surgery
3.7.3.4. Vaccination
3.7.3.5. Others
3.8. Market Attractiveness Analysis: Service
3.9. Global Equine Veterinary Therapeutics Market Outlook: Distribution Channel
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2019-2023
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2024-2033
3.9.3.1. Veterinary Hospital
3.9.3.2. Veterinary Clinics
3.9.3.3. Pharmacies and drug stores
3.9.3.4. E-commerce
3.9.3.5. Other
3.10. Market Attractiveness Analysis: Distribution Channel
4. Global Equine Veterinary Therapeutics Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019-2023
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2024-2033
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Equine Veterinary Therapeutics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
5.3.1. By Country
5.3.2. By Drugs
5.3.3. By Route of Administration
5.3.4. By Service
5.3.5. By Distribution Channel
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2033
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2024-2033
5.5.1. Anti- Inflammatory
5.5.2. Anti - Infective
5.5.3. Parasiticides
5.5.4. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2024-2033
5.6.1. Oral
5.6.2. Parental
5.6.3. Topical
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2024-2033
5.7.1. Diagnostic Tests and Imaging
5.7.2. Physical Health Monitoring
5.7.3. Surgery
5.7.4. Vaccination
5.7.5. Others
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2024-2033
5.8.1. Veterinary Hospital
5.8.2. Veterinary Clinics
5.8.3. Pharmacies and drug stores
5.8.4. E-commerce
5.8.5. Other
5.9. Market Attractiveness Analysis
6. Europe Equine Veterinary Therapeutics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
6.3.1. By Country
6.3.2. By Drugs
6.3.3. By Route of Administration
6.3.4. By Service
6.3.5. By Distribution Channel
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2033
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. T rkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2024-2033
6.5.1. Anti- Inflammatory
6.5.2. Anti - Infective
6.5.3. Parasiticides
6.5.4. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2024-2033
6.6.1. Oral
6.6.2. Parental
6.6.3. Topical
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2024-2033
6.7.1. Diagnostic Tests and Imaging
6.7.2. Physical Health Monitoring
6.7.3. Surgery
6.7.4. Vaccination
6.7.5. Others
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2024-2033
6.8.1. Veterinary Hospital
6.8.2. Veterinary Clinics
6.8.3. Pharmacies and drug stores
6.8.4. E-commerce
6.8.5. Other
6.9. Market Attractiveness Analysis
7. East Asia Equine Veterinary Therapeutics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
7.3.1. By Country
7.3.2. By Drugs
7.3.3. By Route of Administration
7.3.4. By Service
7.3.5. By Distribution Channel
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2033
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2024-2033
7.5.1. Anti- Inflammatory
7.5.2. Anti - Infective
7.5.3. Parasiticides
7.5.4. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2024-2033
7.6.1. Oral
7.6.2. Parental
7.6.3. Topical
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2024-2033
7.7.1. Diagnostic Tests and Imaging
7.7.2. Physical Health Monitoring
7.7.3. Surgery
7.7.4. Vaccination
7.7.5. Others
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2024-2033
7.8.1. Veterinary Hospital
7.8.2. Veterinary Clinics
7.8.3. Pharmacies and drug stores
7.8.4. E-commerce
7.8.5. Other
7.9. Market Attractiveness Analysis
8. South Asia & Oceania Equine Veterinary Therapeutics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
8.3.1. By Country
8.3.2. By Drugs
8.3.3. By Route of Administration
8.3.4. By Service
8.3.5. By Distribution Channel
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2033
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2024-2033
8.5.1. Anti- Inflammatory
8.5.2. Anti - Infective
8.5.3. Parasiticides
8.5.4. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2024-2033
8.6.1. Oral
8.6.2. Parental
8.6.3. Topical
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2024-2033
8.7.1. Diagnostic Tests and Imaging
8.7.2. Physical Health Monitoring
8.7.3. Surgery
8.7.4. Vaccination
8.7.5. Others
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2024-2033
8.8.1. Veterinary Hospital
8.8.2. Veterinary Clinics
8.8.3. Pharmacies and drug stores
8.8.4. E-commerce
8.8.5. Other
8.9. Market Attractiveness Analysis
9. Latin America Equine Veterinary Therapeutics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
9.3.1. By Country
9.3.2. By Drugs
9.3.3. By Route of Administration
9.3.4. By Service
9.3.5. By Distribution Channel
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2033
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2024-2033
9.5.1. Anti- Inflammatory
9.5.2. Anti - Infective
9.5.3. Parasiticides
9.5.4. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2024-2033
9.6.1. Oral
9.6.2. Parental
9.6.3. Topical
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2024-2033
9.7.1. Diagnostic Tests and Imaging
9.7.2. Physical Health Monitoring
9.7.3. Surgery
9.7.4. Vaccination
9.7.5. Others
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2024-2033
9.8.1. Veterinary Hospital
9.8.2. Veterinary Clinics
9.8.3. Pharmacies and drug stores
9.8.4. E-commerce
9.8.5. Other
9.9. Market Attractiveness Analysis
10. Middle East & Africa Equine Veterinary Therapeutics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
10.3.1. By Country
10.3.2. By Drugs
10.3.3. By Route of Administration
10.3.4. By Service
10.3.5. By Distribution Channel
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2033
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drugs, 2024-2033
10.5.1. Anti- Inflammatory
10.5.2. Anti - Infective
10.5.3. Parasiticides
10.5.4. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2024-2033
10.6.1. Oral
10.6.2. Parental
10.6.3. Topical
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2024-2033
10.7.1. Diagnostic Tests and Imaging
10.7.2. Physical Health Monitoring
10.7.3. Surgery
10.7.4. Vaccination
10.7.5. Others
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2024-2033
10.8.1. Veterinary Hospital
10.8.2. Veterinary Clinics
10.8.3. Pharmacies and drug stores
10.8.4. E-commerce
10.8.5. Other
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2023
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Merck Animal Heath
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Affymetrix
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Elanco Animal Health
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Zoetis (Pfizer Animal Health)
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Equine Health UK
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations